These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10308905)

  • 41. Cephalosporin cost reduction.
    Martucci HJ; Parry MF
    Hosp Formul; 1981 Apr; 16(4):396-8, 403. PubMed ID: 10250718
    [No Abstract]   [Full Text] [Related]  

  • 42. Implementation of a service improvement program for ambulatory pharmacy services.
    Hayman JN; Hatwig CA; Crane VS
    Pharm Pract Manag Q; 1996 Oct; 16(3):67-78. PubMed ID: 10166237
    [No Abstract]   [Full Text] [Related]  

  • 43. Monitoring antibiotic prescriptions can reduce use and cost of drugs.
    Douglas AS
    Mod Healthc; 1984 Oct; 14(13):106-7. PubMed ID: 10268397
    [No Abstract]   [Full Text] [Related]  

  • 44. A practical approach to achieving a $950,000 cost savings from a joint anesthesia-pharmacy program.
    Durfee DD
    Hosp Pharm; 1995 Nov; 30(11):957-8, 961-3. PubMed ID: 10152916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effective management of DUE (drug utilization evaluation) policy through a pharmacy clerkship.
    Julius HC
    Hosp Formul; 1993 Sep; 28(9):789-91. PubMed ID: 10128394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cost containment tool for antibiotics.
    Judd C; Moist L; Rose C; Gopaul D
    Dimens Health Serv; 1989 Nov; 66(8):25-6. PubMed ID: 2606294
    [No Abstract]   [Full Text] [Related]  

  • 48. Achieving provider support of pharmacy benefit design.
    Navarro RP
    Med Interface; 1995 Aug; 8(8):80-1, 84. PubMed ID: 10144776
    [No Abstract]   [Full Text] [Related]  

  • 49. Replies to the question: should the practice of drug sampling be retained or eliminated?
    Hosp Formul; 1994 Oct; 29(10):720-2. PubMed ID: 10137849
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial drug use monitoring by a hospital pharmacy.
    Greenlaw CW
    Am J Hosp Pharm; 1977 Aug; 34(8):835-8. PubMed ID: 900135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost controls and patient profiles are the key to pharmacists' health role.
    Kelsky AE; Pasetsky K
    Pharm Times; 1977 Dec; 43(12):70-1. PubMed ID: 10305701
    [No Abstract]   [Full Text] [Related]  

  • 54. Controlling pharmacy inventory...for bottom-line results.
    Harelik JH
    Tex Hosp; 1983 Apr; 38(11):10-1. PubMed ID: 10260502
    [No Abstract]   [Full Text] [Related]  

  • 55. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent monitoring of third generation cephalosporins.
    Freedy HR; Simonelli RJ
    Am J Hosp Pharm; 1986 Jan; 43(1):140-1. PubMed ID: 3953582
    [No Abstract]   [Full Text] [Related]  

  • 57. Reviewing initial choice of antimicrobial therapy--problems for the individual hospital.
    McGowan JE; Cross ML; Walker HK; Shulman JA
    Am J Hosp Pharm; 1979 Mar; 36(3):376-8. PubMed ID: 420234
    [No Abstract]   [Full Text] [Related]  

  • 58. Strengthening the formulary system by implementing a drug usage guidelines program.
    Huber SL; Patry RA; Hudson HD; Godwin HN
    Hosp Formul; 1984 Aug; 19(8):664-8. PubMed ID: 10267390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excessive refills.
    Simonsmeier LM
    Pharm Times; 1982 Dec; 48(12):55-6. PubMed ID: 10261229
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical and economic benefits of a clinical pharmacokinetic service: 1987 versus 1992 data.
    Destache CJ
    Med Interface; 1994 Nov; 7(11):84-6, 89-90. PubMed ID: 10138706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.